Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genentech Resubmits T-DM1 To FDA, This Time With An Overall Survival Benefit

Aug 27 2012

• By Derrick Gingery

Related Content

Plea To FDA: Set Realistic Bar For New Breast Cancer Trial Endpoint

Aug 27 2012

Roche's T-DM1 Early Filing Strategy Backfires As FDA Refuses To File BLA

Aug 30 2010

Buoyed By T-DM1 EMILIA Data, Roche Leaps To Early Breast Cancer Trial

Jun 04 2012

Related Companies

Roche Holding AG

Genentech, Inc.

ImmunoGen, Inc.

GSK plc

Additional Topics

United States Clinical Trials BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window